Viridian Therapeutics Inc. buy BiotechBee
Start price
07.09.22
/
70%
€22.20
Target price
31.05.25
€40.00
Performance (%)
14.41%
End price
05.05.23
€25.40
Summary
This prediction ended on 05.05.23 with a price of €25.40. The BUY prediction by BiotechBee finished with a performance of 14.41%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Viridian Therapeutics Inc. | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to BiotechBee what are the pros and cons of Viridian Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Viridian Therapeutics Inc. diskutieren
Buy mit Kursziel 40,0
In the thread Trading Viridian Therapeutics Inc.
Buy beendet